Laser versus sham for genitourinary syndrome of menopause: A randomised controlled trial - Some crucial criticalities
- PMID: 37041659
- DOI: 10.1111/1471-0528.17489
Laser versus sham for genitourinary syndrome of menopause: A randomised controlled trial - Some crucial criticalities
Comment in
-
Authors' reply.BJOG. 2023 Dec;130(13):1698-1699. doi: 10.1111/1471-0528.17649. Epub 2023 Sep 5. BJOG. 2023. PMID: 37667648 No abstract available.
Comment on
-
Laser versus sham for genitourinary syndrome of menopause: A randomised controlled trial.BJOG. 2023 Feb;130(3):312-319. doi: 10.1111/1471-0528.17335. Epub 2022 Nov 15. BJOG. 2023. PMID: 36349391 Clinical Trial.
Similar articles
-
A Double-Blind Randomized Sham-Controlled Trial to Evaluate the Efficacy of Fractional Carbon Dioxide Laser Therapy on Genitourinary Syndrome of Menopause.J Sex Med. 2021 Apr;18(4):761-769. doi: 10.1016/j.jsxm.2021.01.188. Epub 2021 Mar 20. J Sex Med. 2021. PMID: 33757774 Clinical Trial.
-
Laser versus sham for genitourinary syndrome of menopause: A randomised controlled trial.BJOG. 2023 Feb;130(3):312-319. doi: 10.1111/1471-0528.17335. Epub 2022 Nov 15. BJOG. 2023. PMID: 36349391 Clinical Trial.
-
Update: The Clinical Role of Vaginal Lasers for the Treatment of the Genitourinary Syndrome of Menopause.Urology. 2021 May;151:2-7. doi: 10.1016/j.urology.2020.09.012. Epub 2020 Sep 20. Urology. 2021. PMID: 32966821 Review.
-
Pilot study of fractional CO2 laser therapy for genitourinary syndrome of menopause in gynecologic cancer survivors.Maturitas. 2021 Feb;144:37-44. doi: 10.1016/j.maturitas.2020.10.018. Epub 2020 Dec 2. Maturitas. 2021. PMID: 33358206 Free PMC article. Clinical Trial.
-
[Vaginal laser therapy for urinary incontinence and genitourinary syndrome of menopause : A review].Urologe A. 2019 Mar;58(3):284-290. doi: 10.1007/s00120-019-0861-1. Urologe A. 2019. PMID: 30721329 Review. German.
Cited by
-
CO2 Laser versus Sham Control for the Management of Genitourinary Syndrome of Menopause: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.J Pers Med. 2023 Dec 8;13(12):1694. doi: 10.3390/jpm13121694. J Pers Med. 2023. PMID: 38138921 Free PMC article. Review.
References
REFERENCES
-
- Page A-S, Verbakel JY, Verhaeghe J, Latul YP, Housmans S, Deprest J. Laser versus sham for genitourinary syndrome of menopause: a randomised controlled trial. BJOG. 2023;130(3):312-9.
-
- Salvatore S, Nappi RE, Zerbinati N, Calligaro A, Ferrero S, Origoni M, et al. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Climacteric. 2014;17(4):363-9.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical